Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Advanced Medical Isotope Corporation Banking On Expanded Distributino and Radiogel Technology

(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.



In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future



Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.



Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.



AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.



Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.



That places AMIC right in the middle of a potential growth boom.



While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.



In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.



Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.



Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.



It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.



Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.



Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.



Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.



That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.



Still a developing story worth monitoring.



Disclosure: No position.



Follow ADMD developments and other small cap stocks at VFCsStockHouse.com



Contact VFC's Stock House: vfc@vfcsstockhouse.com



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com

VFC's Stock House

VFC

240-786-2111

vfc@vfcsstockhouse.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Spanish judge orders release of ill boy's parents
2 Sep 2014 at 11:30am

SOTO DEL REAL, Spain (AP) ? Spanish officials have ordered the immediate release of a detained British couple who were wanted by police in the United Kingdom after they took their critically ill child for treatment abroad without doctors' consent.


Final trial confirms efficacy of Sanofi's dengue vaccine
2 Sep 2014 at 10:05pm
By Natalie Huet PARIS (Reuters) - French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease. The final study - conducted on 20,875 children aged 9-16 across five countries in Latin America - confirmed that the vaccine was safe, provided high protection against dengue hemorrhagic fever and cut by 80 percent the risk of hospitalization, the Paris-based company said on Wednesday.

U.S. GMO labeling foes triple spending in first half of this year over 2013
2 Sep 2014 at 9:04pm
By Carey Gillam (Reuters) - Opponents of mandatory labeling for foods made with genetically modified organisms spent more than $27 million in the first six months of this year on GMO-related lobbying, roughly three times their spending in all of 2013, according to an analysis released Wednesday. The Grocery Manufacturers Association (GMA) and major food makers such as Coca-Cola Co and PepsiCo Inc and top biotech seed makers Monsanto Co and DuPont were among heavy spenders on GMO labeling-related lobbying, according to a report issued by the Environmental Working Group. ...


3 Tensions Hiding in Your Body
2 Sep 2014 at 8:38pm

Check for these three subtle tensions that cause shallow breathing and learn how to let go of them with these three effective tips. 1. THE SLIGHTLY-TIGHT ASSI don't mean to be rude; it's just that your butt muscles were not intended to be tense 24/7, and believe it or not, a good number of us are going through life with a tense butt and we don't...



Group says world is losing battle against Ebola
2 Sep 2014 at 8:07pm

UNITED NATIONS (AP) ? The international group Doctors Without Borders warned Tuesday that the world is losing the battle against Ebola and lamented that treatment centers in West Africa have been "reduced to places where people go to die alone."



CDC says Ebola threatens stability of stricken countries
2 Sep 2014 at 7:28pm

By Julie Steenhuysen CHICAGO (Reuters) - The world's worst Ebola outbreak is threatening the stability of affected and neighboring countries in West Africa, and requires a "massive" effort to bring it under control, the head of the U.S. Already we have widespread transmission Liberia. Frieden said the outbreak was the first epidemic of Ebola the world has ever known, meaning it is spreading widely in society and is "threatening the stability" of affected and neighboring countries. The Charlotte, North Carolina-based group did not identify the physician but said he was not treating Ebola patients and that he had isolated himself immediately when symptoms began.


GE's 3D mammography device gets FDA approval
2 Sep 2014 at 7:07pm
(Reuters) - General Electric Co's healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer. According to the company's website, the device, SenoClaire, uses imaging technology that combines low radiation-dosed X-rays from multiple angles to produce a superior mammogram. The device consists of hardware and software upgrades to the company's previously launched Senographe Essential 2D full-field digital mammography system. ...


Double mastectomy doesn't boost cancer survival rates: study
2 Sep 2014 at 6:54pm

Women fighting cancer in one breast don't benefit from having both breasts removed, according to new research out Tuesday, that found long-term survival was equivalent after targeted surgery plus radiation. Hollywood star Angelina Jolie famously announced last year she had a double mastectomy to reduce her risk of one day developing breast cancer, because she has a genetic mutation that substantially increases breast cancer risk. It was the first study to directly compare survival rates between the three main surgical interventions used in breast cancer: a single or a double mastectomy, or a lumpectomy to removing only the cancerous tissue, followed by radiation therapy.



Comedian Joan Rivers still on life support: daughter
2 Sep 2014 at 4:39pm

Comedian Joan Rivers remained on life support on Tuesday after being hospitalized in serious condition due to cardiac arrest last week, her daughter Melissa said. At this time, she does remain on life support," Melissa Rivers said in a statement.


Players using psychologists to find the extra one percent
2 Sep 2014 at 4:28pm
By Simon Cambers NEW YORK (Reuters) - Tennis players are always looking for that extra 1 percent, the unseen edge that could take them to the very top. A common sight for years in golf and now used extensively in sports like cycling and athletics, for a long time it seemed as though tennis players were reluctant to open up their minds, perhaps fearful of what they might find. Murray has had something of a love-hate relationship with sports psychologists over his career, initially finding them a bit odd, unclear how someone who had never played the game would be able to help him on court. Open, with South Africa's Kevin Anderson praising her for helping him win close matches and rebound from tough defeats.


Mississippi woman gets life sentence in fatal buttocks injection case
2 Sep 2014 at 4:25pm

A Mississippi woman convicted of murder for administering an unlicensed silicone buttocks injection to a patient who later died was sentenced on Tuesday to life in prison. Tracey Lynn Garner, 54, performed the unlicensed injection in 2012 in her Jackson home on 37-year-old Karima Gordon, who fell ill immediately after the procedure and died a few days later. A jury last week found Garner guilty of depraved-heart murder. Prosecutors argued during the trial that Garner was motivated by greed. Garner faces a separate trial in the death of Marilyn Hale, an Alabama woman who authorities say died under similar circumstances two years earlier. Lee McDivitt, an investigator for the Mississippi Attorney General's Office, testified during the trial that he found a large bottle of silicone and syringes in Garner's home that were labeled "veterinary use only." Garner, who is transgender, was formerly named Morris Garner.


Wealthy countries must send medical teams to halt Ebola: Medecins Sans Fronti...
2 Sep 2014 at 4:21pm
The worst ever outbreak of the Ebola virus will not be halted unless wealthy nations dispatch specialized biological disaster response teams to West Africa to stop its spread, the head of medical charity Medecins Sans Frontieres said on Tuesday. "Six months into the worst Ebola epidemic in history, the world is losing the battle to contain it," MSF President Joanne Liu said in a speech to United Nations member states. She said aid charities and West African governments did not have the capacity to stem the outbreak and needed intervention by foreign states. The organization is known in the United States as Doctors Without Borders.


West Africa struggles to contain Ebola as warnings and deaths mount
2 Sep 2014 at 4:21pm

Doctors in Liberia were out on strike on Tuesday as they struggled to cope with the outbreak of the deadly Ebola virus, while the United Nations warned the spread of the disease in West Africa was causing food shortages in one of the world's poorest regions. Medical charity Medecins Sans Frontieres (MSF) said 800 more beds for Ebola patients were urgently needed in the Liberian capital Monrovia alone, while in Sierra Leone highly infectious bodies were rotting in the streets. MSF called for rich nations to send military medical teams to support buckling healthcare systems in West Africa.


Dolphin virus adds to deaths in troubled Florida lagoon
2 Sep 2014 at 3:39pm
By Barbara Liston ORLANDO Fla. (Reuters) - A measles-like virus that is blamed for killing hundreds of dolphins on the U.S. East Coast has spread into a Florida lagoon where hundreds of manatees, brown pelicans and dolphins already died mysteriously in recent years. The Indian River Lagoon, south of the Kennedy Space Center, was the scene of the unexplained deaths in 2012 and 2013 and is now threatened by cetacean morbillivirus, which is related to the virus that causes measles in humans. Megan Stolen, a research scientist from the Hubbs-SeaWorld Research Institute, said on Tuesday that the disease was new to Florida's Intercoastal Waterway, which includes the Indian River Lagoon, but that the deaths appear to be over.

Tennis-Players using psychologists to find the extra one percent
2 Sep 2014 at 3:17pm
By Simon Cambers NEW YORK, Sept 2 (Reuters) - Tennis players are always looking for that extra 1 percent, the unseen edge that could take them to the very top. A common sight for years in golf and now used extensively in sports like cycling and athletics, for a long time it seemed as though tennis players were reluctant to open up their minds, perhaps fearful of what they might find. Murray has had something of a love-hate relationship with sports psychologists over his career, initially finding them a bit odd, unclear how someone who had never played the game would be able to help him on court. Open, with South Africa's Kevin Anderson praising her for helping him win close matches and rebound from tough defeats.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC